Mackay Shields LLC’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-64,700
Closed -$1.12M 1218
2021
Q1
$1.12M Sell
64,700
-54,200
-46% -$953K 0.01% 963
2020
Q4
$2.07M Sell
118,900
-23,000
-16% -$367K 0.01% 841
2020
Q3
$1.96M Buy
141,900
+32,500
+30% +$477K 0.01% 797
2020
Q2
$1.58M Sell
109,400
-51,534
-32% -$677K 0.01% 868
2020
Q1
$1.76M Sell
160,934
-120,934
-43% -$2.23M 0.02% 722
2019
Q4
$6.01M Buy
+281,868
New +$6.31M 0.04% 427
2019
Q2
Sell
-35,200
Closed -$685K 1490
2019
Q1
$685K Buy
+35,200
New +$667K 0.01% 1103

Other funds holding SBRA

Mackay Shields LLC's SBRA Position: Q2 2021 in Review

Mackay Shields LLC sold out of Sabra Healthcare REIT (SBRA) in Q2 2021, closing a stake of 64,700 shares — an estimated $1.12M sold.

Mackay Shields LLC first reported a position in SBRA in Q1 2019 and held it in 7 quarters. The position peaked at $6.01M in Q4 2019. 318 funds tracked by Wall St. Rank hold SBRA as of Q2 2021.

  • Mackay Shields LLC reported no remaining Sabra Healthcare REIT position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 64,700 Sabra Healthcare REIT shares in Q2 2021, an estimated $1.12M.
  • Mackay Shields LLC first reported a position in Sabra Healthcare REIT in Q1 2019 and held it in 7 quarters.
  • Mackay Shields LLC's Sabra Healthcare REIT position peaked at $6.01M in Q4 2019.
  • 318 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.